- Sun Pharma's US-based subsidiary Caraco completes tender offer to acquire Dusa Pharma
Drug firm Sun Pharmaceutical Industries today said its US-based subsidiary Caraco has successfully completed the tender offer to acquire Du...
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL Pharma
Sun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Sun Pharma's Caraco gets USFDA nod to resume drug production
Sun Pharmaceutical Industries today said American health regulator has approved resumption of manufacturing operations at its US-based subs...
- Morgan Stanley rates Sun Pharmaceutical Industries overweight
Morgan Stanley has rated Sun Pharmaceutical Industries an 'overweight' after the US Supreme Court ruled in favor of Caraco in the Prandin c...
- Sun Pharmaceutical Industries gets favourable US Supreme Court verdict in patent case
Sun Pharma said the US SC has given a favourable verdict in its patent case against Novo Nordisk over generic Prandin tablets used for trea...
- Pharma major, Sun, back on growth track
After facing a regulatory clampdown by the US FDA in 2009, Caraco has had its manufacturing suspended. It now sells distributed products.
- Sun Pharma plans to delist Caraco, offers share buyback
Sun Pharma said it plans to delist its Detroit-based subsidiary Caraco Pharma from the US bourses by acquiring all the shares of it.
- Caraco may shift production to India
Sun Pharmaceutical Industries' US-based subsidiary Caraco, which is facing a Food and Drug Administration ban on manufacturing, is looking ...
- Sun's Caraco settles litigation with Forest Lab in US
The Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...
- Sun Pharma’s US arm cuts 350 jobs
Sun Pharmaceutical’s US subsidiary, Caraco Pharma, has decided to cut its workforce by more than a half after the recent clampdown by USFDA...
- Sun Pharma's US subsidiary to slash 350 jobs in the US
Sun Pharma's US subsidiary, Caraco Pharmaceutical Laboratories, on Tuesday said that it is slashing 350 jobs.
- Sun Pharma's US arm to reply to USFDA letter on Monday
Sun Pharma's US arm, Caraco Pharmaceutical, will file a response to the US Food and Drug Administration's warning on its quality standards ...
- Regulator issues letter on Manufacturing
After Ranbaxy, Sun Pharma's USbased subsidiary, Caraco has come under the glare of US Food and Drug Administration (FDA) for certain manufa...
- Sun's US arm gets warning from FDA
FDA may withhold approval of pending drug applications of Caraco till the company satisfies the authority’s concerns.
- Sun Pharma subsidiary receives FDA warning letter
Caraco Pharmaceuticals, a subsidiary of Sun Pharma, on Tuesday said it has received a warning letter from United States Food and Drug Admin...
- Sun Pharma shares fall on USFDA notice to Caraco
Sun Pharmaceutical shares dropped after the US Food and Drug Administration issued a warning to its Detroit-based generic subsidiary, Carac...
- Caraco Pharma gets final USFDA nod for Methimazole tablets
Caraco Pharmaceutical Laboratories has received final approval from US Food and Drug Administration for Methimazole tablets in strengths 5 ...